janssen-cilag-international-nv-janssen

Médias

Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat

Médias

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

Médias

Janssen Submits European Marketing Authorisation Application for Canagliflozin in Type 2 Diabetes